INI1/hSNF5-interaction defective HIV-1 IN mutants exhibit impaired particle morphology, reverse transcription and integration in vivo

Retrovirology

Volumn 10, Issue 1, 2013, Pages

  Mathew, Sheeba ^a   Nguyen, Minh ^a   Wu, Xuhong ^a   Pal, Achintya ^a   Shah, Vaibhav B ^b   Prasad, Vinayaka R ^a   Aiken, Christopher ^b   Kalpana, Ganjam V ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

HIV 1; Host factors; IN; INI1; Integration; Morphogenesis; Reverse transcription

Indexed keywords

INTEGRASE; INTEGRASE INTERACTOR 1; RNA DIRECTED DNA POLYMERASE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DEFECTIVE VIRUS; ELECTRON MICROSCOPY; ENZYME ACTIVITY; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PARTICLE SIZE; PROTEIN PROTEIN INTERACTION; RESIDUE ANALYSIS; REVERSE TRANSCRIPTION; SURFACE PROPERTY; TWO HYBRID SYSTEM; VIRION; VIRUS ASSEMBLY; VIRUS DNA CELL DNA INTERACTION; VIRUS ENTRY; VIRUS INFECTIVITY; VIRUS MORPHOGENESIS; VIRUS MUTANT; VIRUS MUTATION; VIRUS PARTICLE; VIRUS REPLICATION;

CELL LINE; CHROMOSOMAL PROTEINS, NON-HISTONE; DNA-BINDING PROTEINS; HIV INTEGRASE; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION; REVERSE TRANSCRIPTION; TRANSCRIPTION FACTORS; VIRION; VIRUS ASSEMBLY; VIRUS INTEGRATION;

HUMAN IMMUNODEFICIENCY VIRUS 1; MIRIDAE;

EID: 84879208264     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-10-66     Document Type: Article

References (46)

1. Adamson CS, Freed EO. Human immunodeficiency virus type 1 assembly, release, and maturation. Adv Pharmacol 2007, 55:347-387.
2. Ganser-Pornillos BK, von Schwedler UK, Stray KM, Aiken C, Sundquist WI. Assembly properties of the human immunodeficiency virus type 1 CA protein. J Virol 2004, 78:2545-2552. 10.1128/JVI.78.5.2545-2552.2004, 369201, 14963157.
3. Carter GC, Bernstone L, Baskaran D, James W. HIV-1 infects macrophages by exploiting an endocytic route dependent on dynamin, Rac1 and Pak1. Virology 2011, 409:234-250. 10.1016/j.virol.2010.10.018, 21056892.
4. Brown P. Integration. Retroviruses 1997, 161-203. Cold Spring harbor Laboratory Press, Coffin JM, Hughes SH, Varmus HE.
5. Briones MS, Chow SA. A new functional role of HIV-1 integrase during uncoating of the viral core. Immunol Res 2010, 48:14-26. 10.1007/s12026-010-8164-z, 20721640.
6. Bukovsky A, Gottlinger H. Lack of integrase can markedly affect human immunodeficiency virus type 1 particle production in the presence of an active viral protease. J Virol 1996, 70:6820-6825. 190728, 8794322.
7. Engelman A. In vivo analysis of retroviral integrase structure and function. Adv Virus Res 1999, 52:411-426.
8. Engleman A, Englund G, Orenstein JM, Martin MA, Craigie R. Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication. J Virol 1995, 69:2729-2736. 188965, 7535863.
9. Gallay P, Hope T, Chin D, Trono D. HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway. Proc Natl Acad Sci U S A 1997, 94:9825-9830. 10.1073/pnas.94.18.9825, 23276, 9275210.
10. Leavitt AD, Robles G, Alesandro N, Varmus HE. Human Immunodeficiency Virus Type 1 Integrase Mutants Retain In Vitro Integrase Activity yet Fail to Integrase Viral DNA Efficiently during Infection. J Virol 1996, 70:721-728. 189872, 8551608.
11. Lu R, Limon A, Devroe E, Silver PA, Cherepanov P, Engelman A. Class II integrase mutants with changes in putative nuclear localization signals are primarily blocked at a postnuclear entry step of human immunodeficiency virus type 1 replication. J Virol 2004, 78:12735-12746. 10.1128/JVI.78.23.12735-12746.2004, 525011, 15542626.
12. Shin C-G, Taddeo B, Haseltine WA, Farnet CM. Genetic analysis of the human immunodeficiency virus type1 integrase protein. J Virol 1994, 64:2421-2425.
13. Taddeo B, Haseltine WA, Farnet CM. Integrase mutants of human immunodeficiency virus type 1 with a specific defect in integration. J Virol 1994, 68:8401-8405. 237311, 7966634.
14. Wiskerchen M, Muesing MA. Human immunodeficiency virus type 1 integrase: Effects of mutations on viral ability to integrate, direct viral gene expression from unintegrated viral DNA templates, and sustain viral propagation in primary cells. J Virol 1995, 69:376-386. 188585, 7983732.
15. Wiskerchen M, Muesing MA. Identification and characterization of a temperature-sensitive mutant of human immunodeficiency virus type 1 by alanine scanning mutagenesis of the integrase gene. J Virol 1995, 69:597-601. 188617, 7983762.
16. Wapling J, Moore KL, Sonza S, Mak J, Tachedjian G. Mutations that abrogate human immunodeficiency virus type 1 reverse transcriptase dimerization affect maturation of the reverse transcriptase heterodimer. J Virol 2005, 79:10247-10257. 10.1128/JVI.79.16.10247-10257.2005, 1182633, 16051818.
17. Chiang CC, Wang SM, Tseng YT, Huang KJ, Wang CT. Mutations at human immunodeficiency virus type 1 reverse transcriptase tryptophan repeat motif attenuate the inhibitory effect of efavirenz on virus production. Virology 2009, 383:261-270. 10.1016/j.virol.2008.10.027, 19019404.
18. Chiang CC, Wang SM, Pan YY, Huang KJ, Wang CT. A single amino acid substitution in HIV-1 reverse transcriptase significantly reduces virion release. J Virol 2010, 84:976-982. 10.1128/JVI.01532-09, 2798345, 19889767.
19. König R, Zhou Y, Elleder D, Diamond TL, Bonamy GM, Irelan JT, Chiang CY, Tu BP, De Jesus PD, Lilley CE, et al. Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 2008, 135:49-60. 10.1016/j.cell.2008.07.032, 2628946, 18854154.
20. Kalpana GV, Marmon S, Wang W, Crabtree GR, Goff SP. Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5 [see comments]. Science 1994, 266:2002-2006. 10.1126/science.7801128, 7801128.
21. Yung E, Sorin M, Pal A, Craig E, Morozov A, Delattre O, Kappes J, Ott D, Kalpana GV. Inhibition of HIV-1 virion production by a transdominant mutant of Integrase interactor 1. Nat Med 2001, 7:920-926. 10.1038/90959, 11479624.
22. Yung E, Sorin M, Wang EJ, Perumal S, Ott D, Kalpana GV. Specificity of interaction of INI1/hSNF5 with retroviral integrases and its functional significance. J Virol 2004, 78:2222-2231. 10.1128/JVI.78.5.2222-2231.2004, 369229, 14963118.
23. Morozov A, Yung E, Kalpana G. Structure-function analysis of integrase interactor 1/hSNF5L1 reveals differential properties of two repeat motifs present in the highly conserved region. Proc Natl Acad Sci USA 1998, 95:1120-1125. 10.1073/pnas.95.3.1120, 18693, 9448295.
24. Craig E, Zhang ZK, Davies KP, Kalpana GV. A masked NES in INI1/hSNF5 mediates hCRM1-dependent nuclear export: implications for tumorigenesis. EMBO J 2002, 21:31-42. 10.1093/emboj/21.1.31, 125819, 11782423.
25. Cano J, Kalpana GV. Inhibition of Early Stages of HIV-1 Assembly by INI1/hSNF5 Transdominant Negative Mutant S6. J Virol 2011, 85:2254-2265. 10.1128/JVI.00006-10, 3067803, 21159874.
26. Sorin M, Yung E, Wu X, Kalpana GV. HIV-1 replication in cell lines harboring INI1/hSNF5 mutations. Retrovirology 2006, 3:56. 10.1186/1742-4690-3-56, 1592304, 16945155.
27. Miller MD, Bushman FD. HIV integration. Ini1 for integration?. Curr Biol 1995, 5:368-370. 10.1016/S0960-9822(95)00074-1, 7627549.
28. Lesbats P, Botbol Y, Chevereau G, Vaillant C, Calmels C, Arneodo A, Andreola ML, Lavigne M, Parissi V. Functional Coupling between HIV-1 Integrase and the SWI/SNF Chromatin Remodeling Complex for Efficient in vitro Integration into Stable Nucleosomes. PLoS Pathog 2011, 7:e1001280. 10.1371/journal.ppat.1001280, 3037357, 21347347.
29. Sorin M, Cano J, Das S, Mathew S, Wu X, Davies KP, Shi X, Cheng SW, Ott D, Kalpana GV. Recruitment of a SAP18-HDAC1 complex into HIV-1 virions and its requirement for viral replication. PLoS Pathog 2009, 5:e1000463. 10.1371/journal.ppat.1000463, 2685004, 19503603.
30. Das S, Kalpana GV. Reverse two-hybrid screening to analyze protein-protein interaction of HIV-1 viral and cellular proteins. Methods Mol Biol 2009, 485:271-293. 10.1007/978-1-59745-170-3_19, 19020832.
31. Maroun M, Delelis O, Coadou G, Bader T, Segeral E, Mbemba G, Petit C, Sonigo P, Rain JC, Mouscadet JF, et al. Inhibition of early steps of HIV-1 replication by SNF5/Ini1. J Biol Chem 2006, 281:22736-22743. 10.1074/jbc.M604849200, 16772295.
32. Krissinel E, Henrick K. Inference of macromolecular assemblies from crystalline state. J Mol Biol 2007, 372:774-797. 10.1016/j.jmb.2007.05.022, 17681537.
33. Jacobs E, Gheysen D, Thines D, Francotte M, de Wilde M. The HIV-1 Gag precursor Pr55gag synthesized in yeast is myristoylated and targeted to the plasma membrane. Gene 1989, 79:71-81. 10.1016/0378-1119(89)90093-0, 2673935.
34. Wang JY, Ling H, Yang W, Craigie R. Structure of a two-domain fragment of HIV-1 integrase: implications for domain organization in the intact protein. EMBO J 2001, 20:7333-7343. 10.1093/emboj/20.24.7333, 125787, 11743009.
35. Hehl EA, Joshi P, Kalpana GV, Prasad VR. Interaction between human immunodeficiency virus type 1 reverse transcriptase and integrase proteins. J Virol 2004, 78:5056-5067. 10.1128/JVI.78.10.5056-5067.2004, 400328, 15113887.
36. Wu X, Liu H, Xiao H, Conway JA, Hehl E, Kalpana GV, Prasad V, Kappes JC. Human immunodeficiency virus type 1 integrase protein promotes reverse transcription through specific interactions with the nucleoprotein reverse transcription complex. J Virol 1999, 73:2126-2135. 104457, 9971795.
37. Shah VB, Aiken C. In vitro uncoating of HIV-1 cores. J Vis Exp 2011, 57:e3384.
38. Cherepanov P, Maertens G, Proost P, Devreese B, Van Beeumen J, Engelborghs Y, De Clercq E, Debyser Z. HIV-1 integrase forms stable tetramers and associates with LEDGF/p75 protein in human cells. J Biol Chem 2003, 278:372-381.
39. Hamamoto S, Nishitsuji H, Amagasa T, Kannagi M, Masuda T. Identification of a novel human immunodeficiency virus type 1 integrase interactor, Gemin2, that facilitates efficient viral cDNA synthesis in vivo. J Virol 2006, 80:5670-5677. 10.1128/JVI.02471-05, 1472599, 16731905.
40. Jiang J, Ablan SD, Derebail S, Hercik K, Soheilian F, Thomas JA, Tang S, Hewlett I, Nagashima K, Gorelick RJ, et al. The interdomain linker region of HIV-1 capsid protein is a critical determinant of proper core assembly and stability. Virology 2011, 421:253-265. 10.1016/j.virol.2011.09.012, 3573886, 22036671.
41. Yufenyuy EL, Aiken C. The NTD-CTD intersubunit interface plays a critical role in assembly and stabilization of the HIV-1 capsid. Retrovirology 2013, 10:29. 10.1186/1742-4690-10-29, 3623829, 23497318.
42. Iordanskiy S, Berro R, Altieri M, Kashanchi F, Bukrinsky M. Intracytoplasmic maturation of the human immunodeficiency virus type 1 reverse transcription complexes determines their capacity to integrate into chromatin. Retrovirology 2006, 3:4. 10.1186/1742-4690-3-4, 1360674, 16409631.
43. Das S, Cano J, Kalpana GV. Multimerization and DNA binding properties of INI1/hSNF5 and its functional significance. J Biol Chem 2009, 284:19903-19914. 10.1074/jbc.M808141200, 2740416, 19398554.
44. Kalpana GV, Goff SP. Genetic analysis of homomeric interactions of human immunodeficiency virus type 1 integrase using the yeast two-hybrid system. Proc Natl Acad Sci USA 1993, 90:10593-10597. 10.1073/pnas.90.22.10593, 47823, 8248150.
45. Butler SL, Hansen MS, Bushman FD. A quantitative assay for HIV DNA integration in vivo. Nat Med 2001, 7:631-634. 10.1038/87979, 11329067.
46. Liszewski MK, Yu JJ, O'Doherty U. Detecting HIV-1 integration by repetitive-sampling Alu-gag PCR. Methods 2009, 47:254-260. 10.1016/j.ymeth.2009.01.002, 2862469, 19195495.